mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.23 |
9e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.26 |
4e-06 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
6e-06 |